Genicular Nerve Radiofrequency Ablation for Chronic Knee Pain After Total Knee Arthroplasty
CompletedNCT05130216
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Determine if genicular nerve radiofrequency ablation (RFA) is a clinically effective intervention for patients with chronic knee pain post-total knee arthroplasty (TKA) as defined by pain.
Study details
- Official title
- A Single-arm Pilot Study of Genicular Nerve Radiofrequency Ablation for Chronic Knee Pain After Total Knee Arthroplasty
- Conditions
- Total Knee Arthroplasty
- Interventions
- Other: Genicular Nerve Radiofrequency Ablation
- Sponsor
- University of Utah
- Start date
- 2021-09-22
- Primary completion
- 2025-10-01
- Sex
- All
- Age range
- from 30 Years to 90 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Age 30 to 90 years * At least one year post TKA * Have no indications for revision TKA * ≥4/10 knee pain for \>6 months following TKA * ≥80% relief with diagnostic genicular nerve blocks * Willingness to undergo fluoroscopy-guided genicular nerve RFA treatment. Exclusion Criteria: * Conditions that preclude RFA (e.g. pregnancy, pacemaker/ICD, severe cardiac/pulmonary compromise; acute illness/infection; coagulopathy or bleeding disorder; allergic reactions/contraindications to a local anesthetic. * Inability to write, speak or read in English * Patient refusal * Significant psychiatric comorbidity
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05130216